Home › Atherosclerosis › South Dakota
Atherosclerosis clinical trials in South Dakota
3 studies for Atherosclerosis are looking for participants at sites in South Dakota.
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Monument Health Clinical Research, Rapid City
RecruitingPhase 3
Ages 45 to 99 · All sexes · Updated Oct 5, 2026 · NCT07037433Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Circle Clinical Research, Sioux Falls
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07157774A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Rapid City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.